+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Opiant Pharmaceuticals Inc - logo

Opiant Pharmaceuticals is a specialty pharmaceutical company that develops opioid antagonist treatments for addictions and related disorders. The company’s portfolio includes NARCAN nasal spray, a treatment to reverse opioid overdoses. It is also involved in developing treatments for binge eating disorder and cocaine use disorder, as well as Bulimia Nervosa. Formerly known as Lightlake Therapeutics, it changed its name in January 2016. Opiant Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Santa Monica, California.

Transmucosal Drug Delivery Devices - Medical Devices Pipeline Product Landscape, 2021 - Product Thumbnail Image

Transmucosal Drug Delivery Devices - Medical Devices Pipeline Product Landscape, 2021

  • Report
  • August 2021
  • 210 Pages
  • Global
From
Intranasal Therapeutics and Drug Delivery Systems Market Distribution by Target Indication, Type of Molecule and Geography: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Intranasal Therapeutics and Drug Delivery Systems Market Distribution by Target Indication, Type of Molecule and Geography: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • February 2022
  • 252 Pages
  • Global
From
Generics Market: Focus on Value-Added Medicines / Supergenerics, 2019-2030 - Product Thumbnail Image

Generics Market: Focus on Value-Added Medicines / Supergenerics, 2019-2030

  • Report
  • October 2019
  • 231 Pages
  • Global
From
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2019-2024 - Product Thumbnail Image

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2019-2024

  • Report
  • March 2024
  • 650 Pages
  • Global
From
Naloxone Spray Global Market Report 2024 - Product Thumbnail Image

Naloxone Spray Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
Opioid Use Disorder (OUD) Global Market Report 2024 - Product Thumbnail Image

Opioid Use Disorder (OUD) Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Opioids Global Market Report 2024 - Product Thumbnail Image

Opioids Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Drug Overdose Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Drug Overdose Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 76 Pages
  • Global
From
Appetite (Eating) Disorders - Global Clinical Trials Review, 2022 - Product Thumbnail Image

Appetite (Eating) Disorders - Global Clinical Trials Review, 2022

  • Clinical Trials
  • February 2022
  • 282 Pages
  • Global
From
Appetite (Eating) Disorders Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Appetite (Eating) Disorders Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • August 2020
  • 254 Pages
  • Global
From
Opiant Pharmaceuticals (OPNT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Opiant Pharmaceuticals (OPNT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2024
  • 85 Pages
From
Opiant Pharmaceuticals Inc (OPNT) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Opiant Pharmaceuticals Inc (OPNT) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • December 2022
  • 55 Pages
From
Loading Indicator